CN1610657A - 制备用于合成他汀类衍生物、特别是7-氨基3,5-二羟基庚酸衍生物的中间体的方法,及其中间体 - Google Patents
制备用于合成他汀类衍生物、特别是7-氨基3,5-二羟基庚酸衍生物的中间体的方法,及其中间体 Download PDFInfo
- Publication number
- CN1610657A CN1610657A CNA028135342A CN02813534A CN1610657A CN 1610657 A CN1610657 A CN 1610657A CN A028135342 A CNA028135342 A CN A028135342A CN 02813534 A CN02813534 A CN 02813534A CN 1610657 A CN1610657 A CN 1610657A
- Authority
- CN
- China
- Prior art keywords
- protecting group
- formula
- compound
- hydrogen
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/30—Preparation of optical isomers
- C07C227/32—Preparation of optical isomers by stereospecific synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/74—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01810670 | 2001-07-06 | ||
EP01810670.8 | 2001-07-06 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010004468XA Division CN101880227A (zh) | 2001-07-06 | 2002-07-02 | 一种用于制备适合于制备他汀类衍生物的中间体化合物的方法及其中间体 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1610657A true CN1610657A (zh) | 2005-04-27 |
Family
ID=8184014
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA028135342A Pending CN1610657A (zh) | 2001-07-06 | 2002-07-02 | 制备用于合成他汀类衍生物、特别是7-氨基3,5-二羟基庚酸衍生物的中间体的方法,及其中间体 |
CN201010004468XA Pending CN101880227A (zh) | 2001-07-06 | 2002-07-02 | 一种用于制备适合于制备他汀类衍生物的中间体化合物的方法及其中间体 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010004468XA Pending CN101880227A (zh) | 2001-07-06 | 2002-07-02 | 一种用于制备适合于制备他汀类衍生物的中间体化合物的方法及其中间体 |
Country Status (17)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108033899A (zh) * | 2017-12-06 | 2018-05-15 | 浙江科技学院 | 一种(r)-6-氰基-5-羟基-3-羰基己酸叔丁酯的制备方法 |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6101484A (en) | 1999-03-31 | 2000-08-08 | Mercata, Inc. | Dynamic market equilibrium management system, process and article of manufacture |
WO2002057229A1 (en) | 2001-01-19 | 2002-07-25 | Biocon India Limited | FORM V CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ß,$G(D)-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1- HEPTANOIC ACID HEMI CALCIUM SALT. (ATORVASTATIN) |
KR20040017278A (ko) * | 2001-07-06 | 2004-02-26 | 테바 파마슈티컬 인더스트리즈 리미티드 | 7-아미노 신 3,5-디히드록시 헵탄산 유도체의 제조 방법,그 중간체 및 상기 중간체의 제조 방법 |
DK1417180T3 (da) | 2001-07-13 | 2007-04-10 | Astrazeneca Uk Ltd | Fremstilling af aminopyrimidinforbindelser |
US7361772B2 (en) | 2001-08-16 | 2008-04-22 | Biocon Limited | Process for the production of atorvastatin calcium |
BR0215644A (pt) | 2002-03-18 | 2004-12-21 | Biocon Ltd | Inibidores de redutase de hmg-coa amorfos do tamanho de partìcula desejado |
US7179942B2 (en) | 2002-07-05 | 2007-02-20 | Bicon Limited | Halo-substituted active methylene compounds |
EP1480943A2 (en) * | 2002-11-15 | 2004-12-01 | Teva Pharmaceutical Industries Limited | Synthesis of 3,5-dihydroxy-7-pyrrol-1-yl heptanoic acids |
AU2003231926A1 (en) | 2003-04-22 | 2004-11-19 | Biocon Limited | NOVEL PROCESS FOR STEREOSELECTIVE REDUCTION OF ss-KETOESTERS |
US7557238B2 (en) | 2003-09-18 | 2009-07-07 | Biocon Limited | Process for the preparation of tert-butyl 6-cyano-5-hydroxy-3-oxohexanoate |
GB0428328D0 (en) | 2004-12-24 | 2005-02-02 | Astrazeneca Uk Ltd | Chemical process |
WO2007034909A1 (ja) * | 2005-09-22 | 2007-03-29 | Kaneka Corporation | (3r,5r)-7-アミノ-3,5-ジヒドロキシヘプタン酸誘導体の製造法 |
KR20100080432A (ko) * | 2008-12-29 | 2010-07-08 | 한미약품 주식회사 | 스타틴 화합물의 신규 제조방법 및 이에 사용되는 벤조티아졸릴 술폰 화합물 |
US20130178636A1 (en) * | 2010-09-16 | 2013-07-11 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Esters of hexanoic acids as intermediates for the preparation of atorvastatin |
US8420773B2 (en) | 2011-05-06 | 2013-04-16 | Basf Se | Process for producing water-absorbing polymer particles |
EP2705075B1 (de) | 2011-05-06 | 2016-12-21 | Basf Se | Verfahren zur herstellung wasserabsorbierender polymerpartikel |
AU2012345473B2 (en) * | 2011-11-28 | 2017-05-25 | Mylan Laboratories Ltd | Process for producing chiral statin side chain intermediates employing candida|antarctica lipase B |
US10149720B2 (en) | 2013-03-08 | 2018-12-11 | Auris Health, Inc. | Method, apparatus, and a system for facilitating bending of an instrument in a surgical or medical robotic environment |
EP2778229A1 (de) * | 2013-03-11 | 2014-09-17 | Sandoz Ag | Verfahren zur enantioselektiven Herstellung von 3-Hydroxyglutarsäuremonoestern und deren Verwendung |
US10376672B2 (en) | 2013-03-15 | 2019-08-13 | Auris Health, Inc. | Catheter insertion system and method of fabrication |
CA2944989A1 (en) | 2013-04-08 | 2014-10-16 | Cytodyn Inc. | Felinized antibodies and methods of treating retroviral infections in felines |
CN104230879B (zh) * | 2014-08-15 | 2016-08-24 | 新发药业有限公司 | 一种2-((4r, 6s)-6-甲酰基-2,2-二取代基-1,3-二氧六环-4-基)乙酸酯制备方法 |
CN108997324A (zh) * | 2018-08-21 | 2018-12-14 | 南京欧信医药技术有限公司 | 瑞舒伐他汀钙中间体的制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4677211A (en) * | 1984-06-29 | 1987-06-30 | Sandoz Pharmaceuticals Corp. | Preparation of lactones |
US4950775A (en) | 1985-10-11 | 1990-08-21 | University Of California | Antihypercholesterolemic compounds and synthesis thereof |
US5003080A (en) | 1988-02-22 | 1991-03-26 | Warner-Lambert Company | Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis |
IT1226726B (it) * | 1988-07-29 | 1991-02-05 | Zambon Spa | Composti attivi come inibitori della biosintesi del colesterolo. |
US5196440A (en) * | 1988-07-29 | 1993-03-23 | Zambon Group S.P.A. | Compounds active as inhibitors of the cholesterol biosynthesis |
IT1224795B (it) * | 1988-12-01 | 1990-10-24 | Sigma Tau Ind Farmaceuti | Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento |
IT1237792B (it) | 1989-12-21 | 1993-06-17 | Zambon Spa | Composti attivi come inibitori dell'enzima hmg-coa reduttasi |
US5155251A (en) | 1991-10-11 | 1992-10-13 | Warner-Lambert Company | Process for the synthesis of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate |
JP3652394B2 (ja) * | 1995-01-27 | 2005-05-25 | 高砂香料工業株式会社 | N−置換−7−アミノ−5−ヒドロキシ−3−オキソヘプタン酸誘導体およびその製造法 |
US6743926B2 (en) * | 2000-05-26 | 2004-06-01 | Ciba Specialty Chemicals Corporation | Process for the preparation of indole derivatives and intermediates of the process |
KR20040017278A (ko) | 2001-07-06 | 2004-02-26 | 테바 파마슈티컬 인더스트리즈 리미티드 | 7-아미노 신 3,5-디히드록시 헵탄산 유도체의 제조 방법,그 중간체 및 상기 중간체의 제조 방법 |
WO2003004456A1 (en) | 2001-07-06 | 2003-01-16 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives |
AU2002328835A1 (en) | 2001-07-06 | 2003-01-21 | Teva Pharmaceutical Industries Ltd | Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation |
-
2002
- 2002-07-02 KR KR20047000163A patent/KR20040017278A/ko not_active Application Discontinuation
- 2002-07-02 CA CA002448917A patent/CA2448917A1/en not_active Abandoned
- 2002-07-02 WO PCT/EP2002/007307 patent/WO2003004450A1/en active Application Filing
- 2002-07-02 EP EP09176993A patent/EP2161250A1/en not_active Withdrawn
- 2002-07-02 PT PT02764615T patent/PT1404642E/pt unknown
- 2002-07-02 PL PL02366392A patent/PL366392A1/xx not_active Application Discontinuation
- 2002-07-02 US US10/482,463 patent/US7420078B2/en not_active Expired - Fee Related
- 2002-07-02 CN CNA028135342A patent/CN1610657A/zh active Pending
- 2002-07-02 CN CN201010004468XA patent/CN101880227A/zh active Pending
- 2002-07-02 EP EP02782448A patent/EP1404639A1/en not_active Withdrawn
- 2002-07-02 CZ CZ2004150A patent/CZ2004150A3/cs unknown
- 2002-07-02 BR BR0210842-9A patent/BR0210842A/pt not_active IP Right Cessation
- 2002-07-02 JP JP2003510418A patent/JP2004533479A/ja active Pending
- 2002-07-02 IL IL15905002A patent/IL159050A0/xx not_active IP Right Cessation
- 2002-07-02 AU AU2002354701A patent/AU2002354701B2/en not_active Ceased
- 2002-07-02 ES ES02764615T patent/ES2340260T3/es not_active Expired - Lifetime
- 2002-07-02 KR KR20047000160A patent/KR20040017277A/ko not_active Application Discontinuation
- 2002-07-02 HU HU0401145A patent/HUP0401145A3/hu unknown
- 2002-07-05 AR ARP020102537A patent/AR034735A1/es not_active Application Discontinuation
- 2002-07-05 AR ARP020102535A patent/AR034733A1/es unknown
- 2002-07-05 AR ARP020102536A patent/AR034734A1/es not_active Application Discontinuation
-
2004
- 2004-02-05 HR HR20040119A patent/HRPK20040119B3/xx not_active IP Right Cessation
-
2008
- 2008-07-24 US US12/220,390 patent/US7855302B2/en not_active Expired - Fee Related
-
2010
- 2010-11-04 US US12/939,401 patent/US8026383B2/en not_active Expired - Fee Related
-
2011
- 2011-07-19 IL IL214164A patent/IL214164A0/en unknown
- 2011-07-19 IL IL214165A patent/IL214165A0/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108033899A (zh) * | 2017-12-06 | 2018-05-15 | 浙江科技学院 | 一种(r)-6-氰基-5-羟基-3-羰基己酸叔丁酯的制备方法 |
CN108033899B (zh) * | 2017-12-06 | 2020-04-10 | 浙江科技学院 | 一种(r)-6-氰基-5-羟基-3-羰基己酸叔丁酯的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
HUP0401145A3 (en) | 2008-08-28 |
EP2161250A1 (en) | 2010-03-10 |
CA2448917A1 (en) | 2003-01-16 |
AR034734A1 (es) | 2004-03-17 |
HRP20040119A2 (en) | 2005-04-30 |
EP1404639A1 (en) | 2004-04-07 |
US20040186313A1 (en) | 2004-09-23 |
JP2004533479A (ja) | 2004-11-04 |
PT1404642E (pt) | 2010-03-29 |
WO2003004450A1 (en) | 2003-01-16 |
IL214164A0 (en) | 2011-08-31 |
AU2002354701B2 (en) | 2007-11-22 |
IL159050A0 (en) | 2004-05-12 |
CZ2004150A3 (cs) | 2004-09-15 |
PL366392A1 (en) | 2005-01-24 |
US7855302B2 (en) | 2010-12-21 |
US7420078B2 (en) | 2008-09-02 |
IL214165A0 (en) | 2011-08-31 |
US20080312466A1 (en) | 2008-12-18 |
ES2340260T3 (es) | 2010-06-01 |
AR034733A1 (es) | 2004-03-17 |
US20110046411A1 (en) | 2011-02-24 |
US8026383B2 (en) | 2011-09-27 |
CN101880227A (zh) | 2010-11-10 |
AR034735A1 (es) | 2004-03-17 |
KR20040017278A (ko) | 2004-02-26 |
HUP0401145A2 (hu) | 2004-09-28 |
KR20040017277A (ko) | 2004-02-26 |
BR0210842A (pt) | 2004-07-13 |
HRPK20040119B3 (en) | 2006-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1610657A (zh) | 制备用于合成他汀类衍生物、特别是7-氨基3,5-二羟基庚酸衍生物的中间体的方法,及其中间体 | |
JPH10512759A (ja) | 酵素触媒作用アシル化による1級及び2級のヘテロ原子置換アミンのラセミ体分割 | |
CN1545502A (zh) | 吲哚衍生物的制备方法 | |
CN1082964C (zh) | 手性的双膦类化合物 | |
JP2011510038A (ja) | ((2s,4r)−4,6−ジヒドロキシテトラヒドロ−2h−ピラン−2−イル)メチルカルボキシラート及び2−デオキシリボース−5−リン酸アルドラーゼを使用の製造方法 | |
SK802004A3 (en) | Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives | |
CN1195759C (zh) | 制备苯并噁嗪衍生物及其中间体的方法 | |
CN1898255A (zh) | 制备吡啶衍生物的方法 | |
JP2004533481A (ja) | 7−アミノsyn3,5−ジヒドロキシヘプタン酸誘導体の製造方法、それらの中間体及び中間体の製造方法 | |
JP2004533481A5 (US07420078-20080902-C00029.png) | ||
CN1082046C (zh) | 2-(2-羟甲基苯基)乙酰胺衍生物的制备方法及其制备用中间体 | |
CN1194960C (zh) | 4,5-二氨基莽草酸衍生物的制备方法 | |
CN1204262C (zh) | 制备旋光活性胺类的方法 | |
CN1538954A (zh) | 用于合成埃坡霉素及其衍生物并经保护的3,5-二羟基-2,2-二甲基-戊腈及其制备方法和应用 | |
JP6027683B2 (ja) | スタチン類の簡便な製造方法 | |
NZ521087A (en) | Method for the enzymatic resolution of the racemates of aminomethy-aryl-cyclohexanol derivatives | |
CN101040053A (zh) | 光学活性(S或R)-β-氨基酸和光学活性(R或S)-β-氨基酸酯的制造方法、以及β-氨基酸2-烷氧基乙酯和光学活性(S或R)-β-氨基酸2-烷氧基乙酯 | |
JP4991543B2 (ja) | ジアリールシクロアルキル誘導体の製造方法 | |
CN1087337A (zh) | 取代的喹啉-2-基甲氧基苯乙酸衍生物 | |
JP5554887B2 (ja) | 光学活性シクロペンテノンの調製プロセス及び該プロセスにより調製されるシクロペンテノン | |
CN1190966A (zh) | 人体免疫缺陷病毒(hiv)蛋白酶抑制剂的制备工艺 | |
EP1811037B1 (en) | Optically active cyclopentenones for use in the peparation of prostaglandins | |
CN1807403A (zh) | 用于合成埃坡霉素及其衍生物并经保护的3,5-二羟基-2,2-二甲基-戊酰胺及其制备方法和应用 | |
CN1484631A (zh) | 对映体纯的羟基酯和酸的制备 | |
CN1553959A (zh) | 制备取代的2-氨基-3-(2-氨基-苯硫基)-丙酸的酶催化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20050427 |
|
C20 | Patent right or utility model deemed to be abandoned or is abandoned |